Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2007
09/12/2007EP1689447A4 Gene transfer for regulating smooth muscle tone
09/12/2007EP1684751B1 Use of 1-thia-dibenzo e,h azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
09/12/2007EP1682528B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES
09/12/2007EP1664059B1 Thienopyrroles as antiviral agents
09/12/2007EP1658093B1 Use of a mixture containing oxytocin and testosteron or estradiol for treating disturbances of psychosocial experiences and behaviour
09/12/2007EP1654263B1 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
09/12/2007EP1648894B1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives
09/12/2007EP1641797B1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo[2,3-d]pyrimidine hydrogen mesylate and its polymorphic forms
09/12/2007EP1613304B1 Dpp-iv inhibitors
09/12/2007EP1599208A4 Antiglucocorticoids for the treatment of postpartum psychosis
09/12/2007EP1575591A4 Heterocycles and uses thereof
09/12/2007EP1567167A4 Methods for treating gastroesophageal reflux disease
09/12/2007EP1562932B9 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
09/12/2007EP1558580B1 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
09/12/2007EP1558579B1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
09/12/2007EP1545467B1 Solid pharmaceutical formulations comprising telmisartan
09/12/2007EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/12/2007EP1526851B1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/12/2007EP1519962B1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
09/12/2007EP1519925B1 Oxazole derivatives and their use as insulin sensitizers
09/12/2007EP1498118B1 Patch and process for producing the same
09/12/2007EP1490382A4 Process of preparing azithromycin and crystalline 9-deoxo-9a-aza-9a-homoerythromycin a hydrate used therein
09/12/2007EP1453830B1 Pyrazolo-pyridine derivatives as antiherpes agents
09/12/2007EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
09/12/2007EP1438379B1 Decontamination of surfaces contaminated with prion-infected material with oxidizing agent-based formulations
09/12/2007EP1407013B1 Mutations in ion channels
09/12/2007EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
09/12/2007EP1404640B1 Hydroxybutyric acid esters of acetylsalicylic acid, their methods of production and application as well as drugs containing them
09/12/2007EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists
09/12/2007EP1395255A4 Cddo-compounds and combination therapies thereof
09/12/2007EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
09/12/2007EP1372615A4 Compounds and compositions for delivering active agents
09/12/2007EP1368038B1 Medicament for the administration of amifostine and related compounds
09/12/2007EP1351694B1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
09/12/2007EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection
09/12/2007EP1303496B1 Pyrimidine derivatives
09/12/2007EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/12/2007EP1272490B1 Sodium salt of an azo derivative of 5-aminosalicylic acid
09/12/2007EP1268305B1 Infusion packet with useful and decorative elements, support member, delivery system and method
09/12/2007EP1202715B1 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates
09/12/2007EP1197227B1 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method
09/12/2007EP1133312B1 Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
09/12/2007EP1061816B1 Products containing polyphenol(s) and l-arginine to stimulate nitric oxide production
09/12/2007EP1019358B2 3,3-diarylpropylamines , their use and preparation
09/12/2007EP0994867B1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine
09/12/2007EP0970127B1 Induction of immunological tolerance to a therapeutic antibody using variants of the said therapeutic antibody
09/12/2007EP0914862B1 Production of a novel adsorbent
09/12/2007EP0842268B1 Methods and compositions for identifying morphogen analogs
09/12/2007EP0835655B1 Antibacterial/bactericidal/antiseptic agent, dermatologic preparation, and detergent composition
09/12/2007EP0776161B2 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells
09/12/2007EP0751926B1 Enhancement of the efficacy of drugs by deuteration
09/12/2007EP0651807B1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
09/12/2007CN101036052A Novel detection device for coronary heart disease and stroke
09/12/2007CN101035798A New process for the preparation of alkyl phosphinic acids
09/12/2007CN101035795A Thiazolyl-dihydro indazoles
09/12/2007CN101035793A Difluoro-substituted imidazopyridines
09/12/2007CN101035792A Novel diazabicyclic aryl derivatives and their medical use
09/12/2007CN101035791A Pyrrolo[1,2-D][1,2-4]triazine as inhibitors of c-JUN N terminal kinases (JNK) and P-38 kinases
09/12/2007CN101035789A (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
09/12/2007CN101035786A Pyrrolopyridine derivatives and their use as CRTH2 antagonists
09/12/2007CN101035785A Novel compounds having an anti-bacterial activity
09/12/2007CN101035783A Urea derivatives as calcium channel blockers
09/12/2007CN101035782A Mif-inhibitors
09/12/2007CN101035781A 2-morpholino-4-pyrimidone compound
09/12/2007CN101035780A Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
09/12/2007CN101035777A Modulators of hcv replication
09/12/2007CN101035775A New hydroxymethylbenzothiazoles amides
09/12/2007CN101035773A HIV inhibiting 1.2.4-triazin-6-one derivates
09/12/2007CN101035772A 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE)
09/12/2007CN101035771A 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE)
09/12/2007CN101035770A Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase ( BACE )
09/12/2007CN101035769A Pyrimidine urea derivatives as kinase inhibitors
09/12/2007CN101035768A Compounds and compositions useful as cathepsin S inhibitors
09/12/2007CN101035767A Substituted phenylacetamides and their use as glucokinase activators
09/12/2007CN101035766A 3-(2-hydroxyphenyl) pyrazoles and their use as HSP90 modulators
09/12/2007CN101035765A 磺酰胺衍生物 Sulfonamide derivatives
09/12/2007CN101035764A 4-trifluoromethoxyphenoxybenzol-4-sulfonic acids, method for the production and use thereof in medicaments
09/12/2007CN101035762A Alkil-pyridines as 11-beta inhibitors for diabetes
09/12/2007CN101035761A 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt
09/12/2007CN101035760A Compounds which potentiate glutamate receptor and uses thereof in medicine
09/12/2007CN101035759A Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
09/12/2007CN101035575A Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions
09/12/2007CN101035562A Sustained local anesthetic composition containing preferably a sugar ester such as saib
09/12/2007CN101035555A Combination anti-viral compositions comprising castanospermine and methods of use
09/12/2007CN101035548A Steroidal saponin pharmaceutical composition, the preparation method and use thereof
09/12/2007CN101035547A Use of compounds containing thiol groups as an efflux pump inhibitor
09/12/2007CN101035546A Glycosylceramide adjuvant for saccharide antigens
09/12/2007CN101035545A Pulmonary administration of an antithrombotic compound
09/12/2007CN101035544A Methods and compositions for treatment of excess nitric oxide or cyanide toxicity
09/12/2007CN101035543A Combination therapies employing vitamin B6 related compounds and ACE inhibitors and uses thereof for the treatment of diabetic disorders
09/12/2007CN101035542A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors
09/12/2007CN101035541A Neuroprotective effect of solubilized UDCA in focal ischemic model
09/12/2007CN101035540A Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
09/12/2007CN101035539A Novel uses of 2-phenyl-substituted imidazotriazinone derivatives
09/12/2007CN101035538A Medicaments for treating chronic respiratory disease
09/12/2007CN101035537A Compositions and methods for treating ophthalmic diseases
09/12/2007CN101035536A Combination of organic compounds
09/12/2007CN101035535A Use of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide to inhibit the tyrosine kinase receptor c-fms
09/12/2007CN101035534A Amino substituted aryloxybenzylpiperidine derivatives
09/12/2007CN101035533A Dual NK1/NK3 antagonists against schizophrenia